Number of SARS-Cov-2 infections, ICU admissions and death in the general population compared to DMARD treated patients as well as calculated incidences
| General population | DMARD-treated patients with rheumatic diseases | |
| Total, n | 1.814.000 | 10.771 |
| SARS-CoV-2 infected, n (%) | 5120 (0.28) | 30 (0.25) |
| ICU, n (%) | 227 (4.4) | 3 (10) |
| Death, n (%) | 226 (4.4) | 0 (0) |
DMARD, disease-modifying antirheumatic drug; ICU, intensive care unit; SARS-CoV-2, severe acute respiratory syndrome coronavirus 2.